hoe 33342 has been researched along with Ovarian Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Busch, TM; Emanuele, MJ; Evans, SM; Fraker, DL; Glatstein, E; Gleason, K; Hahn, SM; Jenkins, K; Koch, CJ; Putt, M; Shin, DB; Wileyto, EP; Zhang, P | 1 |
Connolly, D; Dinulescu, DM; Dombkowski, D; Donahoe, PK; Foster, R; Maclaughlin, DT; Masiakos, PT; Pieretti-Vanmarcke, R; Preffer, F; Szotek, PP | 1 |
Balachandran, R; Curran, DP; Day, BW; Fukui, Y; Jung, WH; Madiraju, C; Montgomery, K; Raccor, BS; Shin, Y; Sikorski, RP; Vogt, A | 1 |
3 other study(ies) available for hoe 33342 and Ovarian Neoplasms
Article | Year |
---|---|
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.
Topics: Appendiceal Neoplasms; Benzimidazoles; Binding, Competitive; Carbocyanines; Colonic Neoplasms; Dihematoporphyrin Ether; Etanidazole; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hydrocarbons, Fluorinated; In Vitro Techniques; Intestine, Small; Male; Microscopy, Fluorescence; Ovarian Neoplasms; Oxygen; Photochemotherapy; Sarcoma | 2004 |
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.
Topics: Animals; Anti-Mullerian Hormone; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; CHO Cells; Cricetinae; Female; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Mice; Ovarian Neoplasms; Signal Transduction; Stem Cells; Testicular Hormones; Verapamil | 2006 |
Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.
Topics: Alkanes; Animals; Benzimidazoles; Binding Sites; Brain Chemistry; Carbamates; Carcinoma; Cattle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Epothilones; Female; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; G2 Phase; HeLa Cells; Histones; Humans; Kinetics; Lactones; Macrolides; Microtubules; Molecular Structure; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Protein Binding; Pyrones; Quantitative Structure-Activity Relationship; Radioligand Assay; Tubulin; Tubulin Modulators | 2008 |